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Abstract
There is a growing global market in healthcare and patients.  And while there is a small body of evidence emerging 
around this phenomenon commonly known as medical tourism there remain significant unanswered policy and 
research questions which need to be addressed. We outline some of the key issues set against the six key disciplinary 
preoccupations of the journal: epidemiology, health economics, health policy ethics, politics of health, health 
management, and health policy. 
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Background
Over recent decades a combination of push and pull factors 
have acted as a catalyst for promoting the rise of international 
travel for the purposes of medical treatment—this is commonly 
known as medical tourism. Key factors associated with the rise 
in the global movement of patients across international borders 
include the growing globalisation and inter-connectedness 
of economic production and trade, new forms of political 
cooperation, technological developments, and a burgeoning 
international market in medical care and services provided 
by health professionals. Medical services offered to patients 
willing to travel to other countries for medical care encompass 
a wide variety of services including bio-ethical treatments 
(fertility, transplantation and stem cell therapies), diagnostic 
tests, and cosmetic, orthopaedic, eye and heart surgery.
The willingness of patients to seek medical services across 
international borders is not a new phenomenon—social elites 
have always travelled to be treated in more advanced health 
care systems. Regional centres have also existed within the 
Middle East where wealthy patients from the Gulf States have 
been willing to travel to Beirut, Cairo and Jordon (1). However 
we are now experiencing both a quantitative and qualitative 
shift in patient mobility. In particular we are witnessing 
unprecedented numbers of patients travelling from richer, 
more developed nations to less developed countries to access 
health services. These shifts are largely driven by the relative 
low-cost of treatment in less developed nations, the availability 
of cheap flights and increased online marketing and consumer 
information about the availability of medical services. 
There are different drivers motivating patients to travel, 
diverse sources of funding to support patient mobility and 
a variety of models of delivering care to medical tourists 
(2–4). The world map of destinations frequented by medical 
tourists would now include a range of competing European 
destinations (Western, Scandinavian, Central and Southern 
Europe, Mediterranean), East and South Asia (India, Malaysia, 
Singapore, Korea and Thailand); South Africa; South and 
Central America (including Brazil, Costa Rica, Cuba and 
Mexico); the Middle East (particularly Dubai and Jordon). 
It appears that geographical proximity is an important, but 
not decisive, factor in shaping providers’ marketing plans, 
with many providers targeting potential patients from local 
regions (5,6). Movement can be both funded out-of-pocket or 
government financed with state support for patient mobility 
driven particularly by a lack of available specialists and 
specialised equipment in home countries. 
Deloitte have suggested that the number of US citizens leaving 
the country in search of medical care stood at 750,000 in 2007 
and projected that the number of medical tourists would be 
between 3 and 5 million by 2010. As US medical tourists are 
thought to represent approximately 10% of the global number 
of medical travellers this would give a global figure of between 
30 and 50 million medical tourists travelling for treatment 
each year (7). However, analysts at McKinsey argue that a more 
accurate worldwide figure would be between 60,000 and 85,000 
medical tourists travelling per year although, these numbers 
do appear rather small and unrealistic (8). It is reported, for 
example, that the Bumrungrad hospital in Bangkok had 
admitted close to 500,000 patients in 2003 (9). By 2005, the 
hospital admitted 93,000 Arab patients alone (10). Given that 
even conservative estimates of medical travellers to India put 
the number at 200,000 (11), alongside figures of 200,000 for 
Cuba (12) and around 60,000 for the UK (13), it would seem 
that the numbers cited by McKinsey are unrealistically low.
Having outlined some of the key changes in patient mobility 
that have emerged over recent decades we now consider the 
key challenges in relation to medical tourism under the six key 
disciplinary preoccupations of the Journal. 
Epidemiology
As noted above, robust and credible data on the numbers and 
flows of medical tourists between nations and the background 
characteristics of medical tourists are notoriously difficult to 
obtain. While there is a general consensus that the medical 
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tourism industry has grown over recent years, and that there 
are well established flows between particular countries and 
geographical regions, there is ongoing debate as to the actual 
and potential size of the medical tourism market. Indeed the 
task of compiling robust figures on medical tourists is beset by a 
number of challenges including a range of rival and competing 
definitions, difficulties in gaining access to data, problems 
associated with ascertaining the motivations of travelling 
patients, and the commercial interests of providers (14). 
Evidence about the clinical outcomes of treatments undertaken 
abroad is also limited. Little is currently known about the relative 
clinical effectiveness and outcomes for particular treatments 
provided by different institutions, clinicians and organisations 
used by medical tourists. Evidence is also lacking on long or 
short-term follow-up of patients returning to their home 
countries. The overseas and (predominantly) private nature of 
delivery may explain why there is such a dearth of information 
about clinical outcomes, post-operative complications, lapses 
in safety, infection and poor professional practice (15). 
Health economics 
Given the travel patterns of medical tourists, the economic 
implications of medical travel are of increasing concern to 
national governments. Financial impacts for source countries 
include the costs that result from overseas surgical treatment 
requiring emergency or remedial treatment within home 
countries as well as the attendant health and social care costs. 
On the other hand, health systems may accrue financial savings 
from citizens travelling overseas for treatment. To date there 
is little systemic collection of evidence or attempts to estimate 
overall health system costs and benefits of medical tourism. 
For destination countries, medical tourism holds many 
attractions for national governments, including the potential 
revenue generated from health services and associated 
visitor spending. There are potential human resource 
benefits with some exporting countries presenting medical 
tourism as attracting back home country health workers 
who had emigrated, thus reversing the ‘brain drain’. Positive 
spillovers of medical tourism may include new sources of 
investment in domestic health services and the diffusion 
of new medical technologies and care pathways among 
domestic healthcare providers. 
Health policy ethics
There are ongoing ethical concerns associated with travelling 
for treatment abroad. Some providers may be prepared to offer 
treatments that are more risky, or to place different emphasis 
on the ethical issues involved. Some countries may seek to 
provide treatments that are illegal or highly experimental (16). 
For example, rewarded kidney donation is illegal in many but 
not all parts of the world (17). 
At the system level, ethical questions include whether economic 
and health benefits do trickle down to local populations and the 
extent to which the use of local healthcare professionals reduces 
the level and quality of health provision for local populations. 
An overarching concern is how the growth of medical 
tourism contributes towards individual health being further 
commercialized and commodified (18). Under pressures 
of commercialization and commodification, relationships 
become shaped by the less elevated values of commercial gain 
rather than professional ethical codes (19).
Politics of health 
For most countries seeking to develop medical tourism, 
prospective providers are typically from the private sector—
although some country strategies do identify opportunities 
for the public sector system to expand into this area  Medical 
tourism initiatives are often launched with a great deal of 
fanfare. Given the country promotion strategies, provider 
exaggeration, and industry ‘grand-standing’ it becomes 
difficult to distinguish rhetoric from reality. 
Plausibly, source countries could develop bilateral relations 
with off-shore medical tourism facilities to leverage cost 
savings. However, even if opportunities for financial benefit 
and reduced waiting lists do exist there may  remain significant 
political objections and sensitivities to such outsourcing (20) 
both for publicly funded systems and those funded through 
private and occupational health insurance. This for example 
helps explain why Medicaid and Medicare in the United States 
do not support patients travelling abroad for treatment despite 
the argument that this would deliver significant financial 
savings to the US Treasury.
Questions remain then about the political will that exists to 
address the system-level impacts. A serious problem when 
searching for reliable data to inform discussions about risks and 
opportunities of medical travel is stakeholders with a vested 
interest who are responsible for providing the data (5,14).
Health management 
Some evidence is now emerging about how medical tourists 
make decisions over the treatments they seek to access and the 
destinations to which they travel to (13,21). Patients appear 
to weigh up different forms of hard data (viz. performance 
measures, quality markers etc.) with soft intelligence (viz. 
information provided by websites, the recommendations of 
family, friends, and exchanges via internet chat rooms) when 
making their decisions over treatment options. Because 
prospective travellers source information from intermediaries, 
direct from websites and internet marketing, and amongst 
networks, it complicates practical attempts to regulate and 
enhance the quality of information provided to prospective 
medical tourists. Website and marketing materials contain 
a plethora of details on External Quality Assessment (EQA), 
registration and accreditation. How EQA and registration 
details are currently presented require significant health 
literacy among website users. Prospective patients may not be 
aware of the lack of clear avenues for redress should treatment 
abroad give rise to unexpected complications. Indeed, legal 
uncertainty and complexity occurs at all phases of treatment 
abroad: access to information, preconsultation, treatment 
itself, aftercare and follow-up. 
Health policy 
This growth of medical tourism raises important issues for 
health policy including how countries should themselves 
respond, as well as issues in relation to transnational 
governance as patients cross international boundaries to seek 
treatment. For destination countries, policy issues include state 
and regional support for medical tourism development and 
whether such activities also benefit the domestic population. 
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For example, hospitals could plausibly cross-subsidise care 
for domestic patients, or help to fund capital investment, such 
as MRI scanners, which are then used by all patients in the 
hospital or health system. 
For source countries, large numbers of medical tourists 
travelling overseas can potentially impact on the viability of 
the domestic health system. Large outflows of high-income 
patients from LMIC for example may reduce revenue and dilute 
political support for the development of local health services. 
But it is also within higher income countries where there are 
possibilities of exacerbating a two-tier healthcare system. If, 
for example, eligibility for services such as fertility treatment 
or dental work is tightened, then those individuals with private 
resources may increasingly circumvent local regulations and 
elect to travel overseas to obtain treatment. 
Payment mechanisms for medical tourism are primarily 
two-fold: government outsourcing and out of pocket. To 
date there has been relatively limited success by medical 
tourist providers in tapping insurance revenue streams. Most 
private insurance policies in the UK for example explicitly 
exempt overseas treatment, whilst standard policy exclusions 
include conception, cosmetic, reconstructive or weight loss 
treatment and dental/oral treatment. These are the type of 
treatments where evidence suggests patients then choose to 
pay out of pocket, both domestically and abroad. Within the 
United States, examples of institutionalised arrangements 
do exist but are rare. 
Concluding remarks
Although patient mobility has become an established feature of 
the global health care landscape we have only limited evidence 
on who is travelling where and for what purpose to help guide 
future policy and regulation in this area. The research challenge 
is therefore to shed more light on this important but under 
researched area of health policy and as we have outlined this 
will require integrating insights and approaches from a range 
of disciplinary perspectives.
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